Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
99.3M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
5.21M
-
Shares change
-
+4.84M
-
Total reported value, excl. options
-
$3.57M
-
Value change
-
+$3.37M
-
Number of buys
-
20
-
Number of sells
-
-9
-
Price
-
$0.68
Significant Holders of PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value (PSTV) as of Q3 2025
30 filings reported holding PSTV - PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value as of Q3 2025.
PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value (PSTV) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.21M shares
of 99.3M outstanding shares and own 5.25% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.45M shares), Altium Capital Management LLC (919K shares), GEODE CAPITAL MANAGEMENT, LLC (813K shares), UBS Group AG (624K shares), BlackRock, Inc. (469K shares), STATE STREET CORP (342K shares), NORTHERN TRUST CORP (265K shares), Scientech Research LLC (147K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (67.3K shares), and MERCER GLOBAL ADVISORS INC /ADV (28.5K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.